# Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

Study · id `cardio:ct-nct04562532` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04562532](<https://clinicaltrials.gov/study/NCT04562532>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04562532

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1720 participants.

## Technical summary

Registry record NCT04562532. Randomized; no masking; primary purpose treatment. Start 2021-02-17 (actual); primary completion 2023-12-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1720 participants (planned count; ClinicalTrials.gov record NCT04562532, source copy `cardio:ctgov-nct04562532-2024-07-24`, retrieved 2026-10-26)
- Started: 2021-02-17 (actual) (ClinicalTrials.gov record NCT04562532, source copy `cardio:ctgov-nct04562532-2024-07-24`, retrieved 2026-10-26)
- Primary completion: 2023-12-10 (actual) (ClinicalTrials.gov record NCT04562532, source copy `cardio:ctgov-nct04562532-2024-07-24`, retrieved 2026-10-26)
- Completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT04562532, source copy `cardio:ctgov-nct04562532-2024-07-24`, retrieved 2026-10-26)
- Countries: United States; Belgium; Canada; Denmark; Netherlands (ClinicalTrials.gov record NCT04562532, source copy `cardio:ctgov-nct04562532-2024-07-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04562532-2024-07-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Firehawk Rapamycin Target Eluting Coronary Stent North American Trial
- Acronym: TARGET-IV\_NA
- Condition: Coronary Artery Disease
- Intervention (Device): Microport Firehawk stent
- Intervention (Device): 2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)
- Lead sponsor: Shanghai MicroPort Medical (Group) Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. (`cardio:org-shanghai-microport-medical-group-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial (`cardio:pubmed-39480379`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f0e279b3be54c6f19120926e7a8a1c8ff06da0888b776d4aa6fd1d7609bcfdb4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
